Gabapentin in Treatment of Muscle Cramps in Patients With Liver Cirrhosis
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Liver Cirrhosis
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Younger than 125 years
- Gender
- Both males and females
Description
• The aim of the study was to assess the efficacy and safety of Gabapentin in the treatment of muscle cramps in patients with liver cirrhosis.
• The aim of the study was to assess the efficacy and safety of Gabapentin in the treatment of muscle cramps in patients with liver cirrhosis.
Tracking Information
- NCT #
- NCT02642484
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Sherief M. Abd-Elsalam, Consultant Hepatology and gastroenterology dept.-Tanta Principal Investigator: A. K. Singal, Professor Division of Gastroenterology and Hepatology, UAB, Birmingham, AL, USA Study Director: Walaa A. Elkhalawany, Lecturer Hepatology and gastroenterology dept.-Tanta
Get Well Soon